Ahmed
M’hamedi
a,
Mark A.
Fox
b,
Andrei S.
Batsanov
b,
Hameed A.
Al-Attar
c,
Andrew P.
Monkman
c and
Martin R.
Bryce
*b
aLaboratory of Structure Determination, Development, and Application of Molecular Material, Department of Chemistry, University of Abdelhamid Ibn Badis BP 227, Mostaganem 27000, Algeria
bDepartment of Chemistry, Durham University, South Road, Durham, DH1 3LE, UK. E-mail: m.r.bryce@durham.ac.uk
cDepartment of Physics, Durham University, South Road, Durham, DH1 3LE, UK
First published on 28th June 2017
In contrast to monoiridium complexes, the study of diiridium complexes as dopants in phosphorescent organic light-emitting devices (PhOLEDs) is largely unexplored. We now describe the syntheses, detailed NMR analyses, X-ray crystal structures and optoelectronic properties of the new cyclometalated diiridium complexes 5 and 6 in which the iridium centres are bridged by oxamidato ligands. These complexes contain diastereomers – the meso form (ΔΛ) and the racemic form consisting of two enantiomers (ΔΔ and ΛΛ) – with anti-oxamidato bridges. The precursor μ-dichloro-bridged complex 4 is very weakly emissive in solution, whereas the oxamidato bridged complexes 5 and 6 are highly emissive (ΦPL 73% and 63%) with short excited state lifetimes of τP 0.84 and 1.16 μs, respectively. Cyclic voltammetry studies demonstrate that the oxamidato bridging ligand plays a role in mediating intramolecular interactions between the iridium centres. Density functional theory (DFT) calculations and time dependent-DFT (TD-DFT) calculations provide further insights into the structural, electronic, and photophysical properties of the complexes in their ground and excited states. Phosphorescent organic light-emitting diodes (PhOLEDs) using complexes 5 and 6 as the emissive dopants in a simple architecture using a solution-processed active layer give bright green electroluminescence with remarkably high luminance (Lmax > 25000 cd m−2) for diiridium complexes.
Cyclometalated diiridium complexes with a μ-dichloro-bridge13 are the standard precursors to homoleptic and heteroleptic monoiridium complexes.14 However, the μ-dichloro-bridged dimers are generally very poorly emissive15,16 (although there are a few exceptions).17,18 Most other diiridium systems also have low luminescence quantum yields19–24 which has focussed the vast majority of research onto the more strongly emissive monoiridium complexes.1–3 However, the bridging ligands within diiridium complexes provide unique potential for additional structural and electronic variations compared to monoiridium systems. High efficiency phosphorescence typically results from preventing non-radiative deactivation by rigidification of the emitter framework25 which can be enhanced by judicious choice of the bridging ligand. Additionally, the presence of a second metal might introduce a larger spin–orbit coupling effect than that associated with a single metal centre.
A few diiridium complexes, especially those with conjugated bridging ligands, are known to possess efficient photoluminescence (ΦPL typically ∼30–60% in solution).26–32 There are even examples of solution photoluminescence quantum yields (PLQYs) up to 100% for diiridium complexes with a bis-N^C-coordinating diarylpyrimidinyl bridging ligand.33 The use of diiridium complexes as dopants in phosphorescent organic light-emitting devices (PhOLEDs) is largely unexplored. However, solution-processed PhOLEDs with external quantum efficiencies (EQEs) of >10% have recently been fabricated by our group (complex 1, Fig. 1)34 and by Yang et al., using a 2-(4-tert-butylphenyl)pyrimidine bridging ligand.35 A few other examples of neutral diiridium PhOLEDs with lower efficiencies and low brightnesses have also been reported.36 A low-efficiency PhOLED using a cationic diiridium emitter has also been demonstrated.37 Therefore, it is important to explore diiridium systems in the search for new families of OLED materials.
The motivation for the present work is to develop the optoelectronic properties and PhOLED applications of diiridium complexes with bridging oxamidato ligands, noting that their C2N2O2 structure is isomeric with the diarylhydrazido bridge of our previous complex 1.34 We reasoned that the rigidity of the bis-coordinated oxamidato ligands could lead to high photo- and electro-luminescence quantum yields. Indeed, Sünkel and co-workers recently showed that complex 2 is a green emitter with ΦPL 60% in degassed dichloromethane solution, although no OLEDs were reported in that work.32 We have now synthesised complexes 5 and 6 and discuss their single-crystal X-ray structures, NMR spectra, electrochemical and photophysical properties. Notably, complex 6 is the first reported example with any substituent (other than hydrogens) on the oxamidato bridge. Density functional theory (DFT) and time dependent DFT (TD-DFT) calculations provide further insights into the structural, electronic, and photophysical properties in the ground and excited states. Phosphorescent organic light-emitting diodes (PhOLEDs) using complex 5 or 6 as the emissive dopant in a solution-processed active layer give bright electroluminescence with luminance values as high as >25000 cd m−2. The present work, therefore, represents the first thorough investigation of the properties of diiridium complexes with bridging oxamidato ligands, including new structural modifications. To our knowledge these data strongly compete with the brightest reported PhOLEDs using bimetallic complexes as the emitter.34,35
![]() | ||
Scheme 1 Reagents and conditions: (i) IrCl3·3H2O, 2-ethoxyethanol, 120 °C, 12 h; (ii) oxamide or N,N′-di-t-butylphenyloxamide, NaOMe, MeOH, 20 °C, 24 h. |
The structures of the dinuclear complexes were confirmed by MALDI mass spectra (Fig. S6, S7 in ESI†), elemental analysis and X-ray crystallography (for 5 and 6). The 1H and 13C NMR spectra of 5 and 6 (see the ESI†) exhibit many peaks, as noted previously for other diiridium complexes,31 due to the presence of isomers – the meso form (ΔΛ) and the racemic form consisting of two enantiomers (ΔΔ and ΛΛ). Furthermore, as noted by Sünkel for complex 2,32 both the syn- and anti-oxamidato bridge structures are feasible, although the anti geometry with N^O coordination at each iridium centre appears more reasonable, as observed unambiguously in the crystal structure of complex 6 (see below) and favoured in the crystal structure of 5. It is well known to be often very laborious, and sometimes not possible, to isolate the isomers of diiridium complexes in their pure form.33,45 We were unable to separate the isomers of 5 or 6 by recrystallisation or chromatography, including HPLC.
Table 1 lists all 13C NMR peak assignments corresponding to the ppy ligands for complexes 4–6. NMR data for complex 2 assigned elsewhere32 where two stereoisomers were observed in a 3:
1 ratio, are also listed. The peaks for 4, 5 and 6 were assigned here with the aid of 2D 1H–1H COSY and 1H–13C correlation (HSQC and HMBC) NMR spectra. The dichloro-bridged complex 4 has only the racemic form (ΔΔ and ΛΛ) due to steric effects preventing the formation of the meso form (ΔΛ) and the higher symmetry of the dichloro-bridge results in one set of 13C NMR peaks for a ppy ligand observed here.
C2 | C3 | C4 | C5 | C6 | C7 | C8 | C9 | C10 | C11 | C12 | |
---|---|---|---|---|---|---|---|---|---|---|---|
2 | |||||||||||
Major | 169.25 | 118.63 | 137.34 | 121.50 | 149.55 | 142.23 | 124.28 | 122.12 | 139.80 | 133.99 | 155.07 |
Isomer | 168.72 | 118.43 | 136.47 | 121.44 | 148.34 | 142.20 | 124.18 | 121.84 | 139.50 | 133.36 | 145.73 |
Difference | 0.53 | 0.20 | 0.87 | 0.06 | 1.21 | 0.03 | 0.10 | 0.28 | 0.30 | 0.63 | 9.34 |
Minor | 169.17 | 118.54 | 137.16 | 121.50 | 149.81 | 142.26 | 124.22 | 122.05 | 139.74 | 133.99 | 155.11 |
Isomer | 168.65 | 118.35 | 136.32 | 121.44 | 148.34 | 142.20 | 124.11 | 121.79 | 139.50 | 133.36 | 145.70 |
Difference | 0.52 | 0.19 | 0.84 | 0.06 | 1.47 | 0.06 | 0.11 | 0.26 | 0.24 | 0.63 | 9.41 |
4 | |||||||||||
168.49 | 120.41 | 150.80 | 123.44 | 151.58 | 144.11 | 123.71 | 121.42 | 129.32 | 130.03 | 144.50 | |
5 | |||||||||||
Major | 169.23 | 119.86 | 150.58 | 122.41 | 149.02 | 144.32 | 124.26 | 120.69 | 129.54 | 132.52 | 154.78 |
Isomer | 168.98 | 119.42 | 149.88 | 122.38 | 147.76 | 144.30 | 123.87 | 120.36 | 129.34 | 132.11 | 144.78 |
Difference | 0.25 | 0.44 | 0.70 | 0.03 | 1.26 | 0.02 | 0.39 | 0.33 | 0.20 | 0.41 | 10.00 |
Minor | 169.20 | 119.76 | 150.48 | 122.51 | 149.23 | 144.35 | 124.29 | 120.72 | 129.50 | 132.66 | 154.71 |
Isomer | 168.91 | 119.45 | 149.72 | 122.50 | 147.65 | 144.25 | 123.85 | 120.38 | 129.39 | 132.24 | 144.78 |
Difference | 0.29 | 0.31 | 0.76 | 0.01 | 1.58 | 0.10 | 0.44 | 0.34 | 0.11 | 0.42 | 9.93 |
6 | |||||||||||
Major | 169.43 | 120.47 | 150.77 | 122.88 | 149.35 | 145.05 | 124.31 | 120.91 | 129.13 | 133.24 | 152.88 |
Isomer | 168.39 | 119.31 | 150.52 | 122.20 | 147.50 | 143.47 | 123.52 | 119.73 | 128.86 | 131.75 | 148.45 |
Difference | 1.04 | 1.16 | 0.25 | 0.68 | 1.85 | 1.58 | 0.79 | 1.18 | 0.27 | 1.49 | 4.43 |
Minor | 169.45 | 120.19 | 150.77 | 122.83 | 149.23 | 145.00 | 124.26 | 120.78 | 129.23 | 133.09 | 152.96 |
Isomer | 168.21 | 119.19 | 150.27 | 122.30 | 147.63 | 143.43 | 123.40 | 119.71 | 128.88 | 132.05 | 148.64 |
Difference | 1.24 | 1.00 | 0.50 | 0.53 | 1.60 | 1.57 | 0.86 | 1.07 | 0.35 | 1.04 | 4.32 |
The NMR data for complexes 5 and 6 indicate the presence of two isomers – the meso form (ΔΛ) and the racemic form (ΔΔ and ΛΛ). A 3:
2 ratio of isomers is observed in both cases but it is unfortunately not possible to assign one form to one set of NMR data corresponding to the major isomer. Similarly, the NMR data for 2 could not be assigned to the isomers, but Sünkel assumed the anti geometry with N^O coordination at each iridium centre for both isomers.32 The proposed anti geometries are indeed supported by X-ray data here. The remarkable similarities between the 13C NMR data for 2 and for 5 with the largest shift differences of 9–10 ppm found for the carbon atom attached to iridium (C12) (Fig. 2) confirm that complexes 2 and 5 contain mixtures of meso (ΔΛ) and racemic (ΔΔ and ΛΛ) anti geometries. The effect of the tert-butylphenyl groups at the nitrogens of the bridge in complex 6 on the 13C NMR shifts compared to those for 5 is obvious with shift differences of over 1 ppm for seven carbons (C2, C3, C6, C7, C9, C11, C12) of the ppy ligands in 6 compared to only two (C6, C12) in 5. Interestingly, the shift differences for C12 in 6 are about half the corresponding values for 2 and 5.
![]() | ||
Fig. 2 Carbon atom numbering used in the NMR peak assignments of 6 in Table 1. This numbering also applies to NMR data of diiridium complexes 2, 4 and 5. |
The thermal stabilities of the diiridium complexes 4–6 were evaluated using thermal gravimetric analysis (TGA) and differential scanning calorimetry (DSC) under a nitrogen atmosphere. The 5% weight loss temperatures (Td) are > 370 °C for all complexes, suggesting the complexes should be thermally stable under the conditions of device operation. TGA and DSC traces for 5 and 6 are shown in Fig. S8–S11, ESI.†
Single crystal X-ray structures (Fig. 3, Table 2 and Fig. S1–S3, ESI†) were obtained for 5·hexane and 6·pentane·PhCl solvates, grown from mixtures of stereoisomers in solution. Molecule 5 lies on a crystallographic two-fold axis which is perpendicular to the bridge plane. As noted by Sünkel et al. for complex 2, the N(H) and O atoms are statistically mixed, hence the stereochemistry of the bridge cannot be established unequivocally; however, for 5 the observed electron density is best fit by an overlap of two alternative anti-configurations, with contributions of 0.64(3) [N trans to C(12)] and 0.36(3) [N trans to C(1)]. A similar (but 0.5:
0.5) disorder has been observed in 2.32 Molecule 6 is the meso (ΔΛ) diastereomer, possessing crystallographic inversion symmetry. In both complexes, Ir atoms have distorted octahedral coordination with the pyridine N atoms trans to each other. The planarity of the Ir(O2C2N2)Ir system in 5 is distorted by a small (4.7°) twist around the C(23)–C(23′) bond. In 6 the O2C2N2 moiety is planar, the Ir atoms are tilted to opposite sides of its plane by 0.14 Å and the mean axes of the tolyl substituents by 19.4°, the bridging N(2) atom is planar-trigonal (sum of bond angles 358.7°). The anti geometry with N^O coordination at each iridium centre is observed unambiguously for the first time in the crystal structure of complex 6.
2 | 5 | 6 | |
---|---|---|---|
a N/O disorder in the bridge. | |||
Ir–O(1) | 2.20(2)a | 2.194(13)a | 2.184(3) |
Ir–N(1) | 2.18(2)a | 2.13(2)a | |
Ir–N(2) | 2.132(15)a | 2.135(18)a | 2.147(3) |
Ir–O(2) | 2.180(15)a | 2.19(2)a | |
Ir–N(3) | 2.030(5) | 2.042(3) | 2.023(4) |
Ir–N(4) | 2.029(5) | 2.032(3) | 2.040(4) |
Ir–C(1) | 1.993(5) | 1.993(4) | 1.982(4) |
Ir–C(12) | 2.008(6) | 2.013(3) | 2.013(4) |
Ir⋯Ir′ | 5.718 | 5.688 | 5.726 |
All chelating phenylpyridine systems are slightly folded, with ph/py interplanar angles in 5 (10.9 and 12.5°) larger than in 6 (3.1 and 6.0°). The twists between pyridine rings and their mesityl substituents are much larger. This is expected due to steric effects involving the ortho-methyl substituents in the mesityl groups. These ortho-methyl groups in each mesityl group are non-equivalent in solution based on the observed solution-state NMR data of 4, 5 and 6 here. In 5, the mesityl group iv is twisted to the pyridine ring ii by 45.0°, whereas mesityl iii is disordered, in the ratio of 0.726(9) to 0.274(9), between two orientations inclined to pyridine ring i by 77.9° and 84.9°, respectively. In 6, the i/iii and ii/iv twists are 71.8° and 61.8°, respectively.
The redox properties of the diiridium complexes 4–6 were studied by cyclic voltammetry (CV) in dichloromethane (DCM) solution at 298 K (Fig. 4) and the data are tabulated along with those reported for 134 and [Ir(ppy)2Cl]217 for comparison in Table 3. CV data were not reported for complex 2 for comparison.32 All complexes display two quasi-reversible, one-electron oxidation waves which are assigned to sequential oxidation of the metal centred Ir3+/Ir4+ redox couples. The half-wave oxidation potentials for 4 are similar to that of [Ir(ppy)2Cl]217 as expected. The iridium atoms in 5 and 6 with first half-wave oxidation potentials of +0.38 to +0.40 V are more easily oxidised than for 4 at +0.56 V due to the stronger electron-withdrawing effect of the oxamidato bridge in 5 and 6 compared to the μ-dichloro bridge in 4. The two isomers of compound 1 have peak separations of 400–410 mV where the bridge plays a significant role in the photophysical properties of 1.34 Although complexes 1, 5 and 6 have similar Ir⋯Ir intramolecular distances, the peak separations observed for 5 and 6 are smaller than for 1 and suggest that oxamidato bridges play a minor role with respect to their photophysical properties. The larger peak separation (ΔE) of 220 mV between the two waves of 6 compared to ΔE 160 mV for 5 suggests the monocation species is more stable for 6 than for 5. This is consistent with more HOMO character on the bridge of 6 compared to 5 (see below). The tert-butylphenyl groups at the bridge must contribute to the increased stability of the monocation from 6 with respect to the monocation from 5.
Complex |
E
ox(1)1/2![]() |
E
ox(2)1/2![]() |
ΔEa (mV) | Ir⋯Ir distance (Å) | HOMOb (eV) | HOMOc (eV) |
---|---|---|---|---|---|---|
a 0.1 M (nBu4NPF6) in DCM at 298 K, scan rate 100 mV s−1, referenced to the internal decamethylferrocene/decamethylferrocenium couple (Fc*Me/Fc*Me+) at −0.55 V with the ferrocenium/ferrocene (FcH/FcH+) couple as reference at 0.00 V. b HOMO levels calculated from CV potentials by HOMO = −4.8 + (−Eox1/2), using ferrocene as the standard. c HOMO energies calculated from optimised geometries at B3LYP/LANL2DZ:3-21G*. | ||||||
1 | +0.22 | +0.63 | 410 | 5.061 | −5.02 | −4.59 |
4 | +0.56 | +0.88 | 320 | 3.812 | −5.36 | −4.91 |
5 | +0.38 | +0.54 | 160 | 5.688 | −5.18 | −4.79 |
6 | +0.40 | +0.62 | 220 | 5.726 | −5.20 | −4.82 |
Ir(ppy)2Cl2 | +0.53 | +0.79 | 260 | 3.771 | −5.33 | −4.98 |
The photophysical data for 4–6 are listed in Table 4, with data for [Ir(ppy)3] included for comparison. The absorption spectral profiles of 4–6 in 2-methylTHF are very similar (Fig. 5a). The high energy peaks are assigned to characteristic ligand-centred (LC) spin-allowed π → π* transitions.46 At longer wavelengths the complexes exhibit a series of weaker peaks between 350 and 520 nm which are attributed to singlet and triplet mixed metal-to-ligand charge transfer states (1MLCT and 3MLCT) with the lowest energy band at 492 nm for 4, and 500 nm for 5 and 6 assigned to the spin-forbidden triplet 3MLCT absorption.46,47 The PL spectra of 4 and 5 show well-defined peaks at λmax 518 and 529 nm, respectively, and like Ir(ppy)3,48 are broad and featureless which indicates a dominant 3MLCT contribution and negligible signature of a ligand centred triplet (3LC) contribution. The PL emission of 6 at λmax 522 nm also has a lower energy shoulder at 550 nm which indicates a higher contribution from the 3LC states for this complex as a result of the additional functionality on the bridge increasing the structural rigidity (Fig. 5b).
Complex | λ Absmax /nm | λ PLmax /nm | PLQYcΦPL/% | τ p /μs |
---|---|---|---|---|
a Data obtained in <10 μM 2-methylTHF solutions at 20 °C. b Data obtained in degassed 2-methylTHF solution with excitation wavelength 340 nm. c Measured relative to Ir(ppy)3ΦPL = 0.97 (ref. 49) in degassed 2-methylTHF at 20 °C: estimated error ± 5%. d The phosphorescence decay lifetimes of thin films prepared by spin-coating on quartz substrate from chlorobenzene solutions in poly(methyl methacrylate): estimated error ± 5%. | ||||
4 | 341, 360, 410, 463, 492 | 518 | 5.6 | N/A |
5 | 315, 350, 415, 470, 500 | 529 | 73 | 0.84 |
6 | 315, 350, 415, 470, 500 | 522 | 63 | 1.164 |
Ir(ppy)3 | 510 | 97 | 1.4 |
![]() | ||
Fig. 5 (a) Normalised absorption spectra of complexes 4–6 in 2-methylTHF. (b) Photoluminescence spectra of complexes 4–6 in 2-methylTHF at 20 °C. |
The photoluminescence quantum yields (PLQYs) of 4, 5 and 6 in deoxygenated 2-methylTHF solutions are 5.6%, 73% and 63%, respectively, compared with the reference complex Ir(ppy)3 at 97%.49 The very low QY for 4 is consistent with previously reported values for other μ-dichloro-bridged dimers.15,16 The considerably higher quantum yields for 5 and 6 demonstrate that enhancement is induced by the oxamidato bridging unit, and the values are consistent with that reported previously for complex 2 (ΦPL 60%).32
The phosphorescence decay lifetimes of thin films of the complexes 4–6 prepared by spin-coating on quartz substrate from chlorobenzene solutions in poly(methyl methacrylate) (PMMA) are shown in Fig. 6. The data for complex 4 deviate from single exponential characteristics, and this is ascribed to the low solubility and aggregation behaviour of this complex in solution which leads to a strong lifetime dispersion corresponding to different aggregated states. Complexes 5 and 6 both have short phosphorescence lifetimes of 0.84 and 1.164 μs, respectively, originating from 3MLCT which indicates strong spin-orbital coupling with the singlet states.
![]() | ||
Fig. 6 Phosphorescence decays of the complexes doped at 5 wt% in inert PMMA matrix on a log-linear scale. Excitation wavelength 355 nm. |
Electronic structure calculations show that the frontier molecular orbitals for 4 resemble those reported17 for Ir(ppy)2Cl2 (Fig. 7). The HOMO has iridium and phenyl contributions whereas the LUMO contain pyridyl character (Table S3, ESI†). Similar orbital make ups are found for meso (ΔΛ) and racemic (ΔΔ) forms of 5 suggesting that the oxamidato bridges contribute little to the frontier orbitals (7–9% bridging character in HOMO, Fig. 7 and Fig. S4 and Tables S4, S5, ESI†). By contrast, the HOMO for complex 6 (ΔΛ) contains substantial oxamidato bridge character (35%) along with HOMO−1 and HOMO−2 being similar in energies to the HOMO (Fig. 8 and Table S6, ESI†). Complex 6 (ΔΔ) has the nature of HOMO, HOMO−1 and HOMO−2 in a different order while they all have similar energies (Fig. S5 and Table S7, ESI†). The greater bridge involvement in the properties of 6 with respect to 5 is supported by cyclic voltammetry and photophysical observations here.
![]() | ||
Fig. 7 Frontier orbitals for 4 (ΔΔ) and 5 (ΔΛ). Contour values are plotted at ±0.035 e bohr−3. The Ir![]() ![]() ![]() ![]() ![]() ![]() |
![]() | ||
Fig. 8 Important orbitals for 6 (ΔΛ). Contour values are plotted at ±0.035 e bohr−3. The Ir![]() ![]() ![]() ![]() ![]() ![]() |
The trend in the computed HOMO energies for 4, 5 and 6 is in good agreement with measured oxidation potentials (Table 3). Complex 4 has a considerably lower HOMO energy than the HOMO energies in 5 and 6; thus 4 has a higher oxidation potential than 5 and 6. The calculated HOMO–LUMO energy gaps are similar at 3.54, 3.46 and 3.44 eV for 4, 5 and 6, respectively, and are in accord with the trend in the observed emission energies. This agreement is supported further by TD-DFT data where the observed lowest absorption energies are in excellent agreement with predicted S0 → T1 energies (Table S8, ESI†).
![]() | ||
Fig. 9 Efficiencies and brightness data for complexes 5 and 6 in the device architecture stated in Table 5, and an energy level diagram for the devices. |
The PhOLED data for 5 and 6 are, therefore, significantly different from data on other diiridium complexes studied in our laboratory,16,17,34 and elsewhere,33,36 demonstrating that properties can be tuned by varying the bridge structure. The high molecular weight of diiridium complexes generally precludes their fabrication into thin films by thermal evaporation, therefore, they are unlikely to achieve the very high EQEs which characterise PhOLEDs of mono-iridium complexes which are deposited by vacuum deposition.53 However, high brightness, as observed for 5 and 6, is widely recognised as an important figure-of-merit for PhOLED characterisation.52 Moreover, the solution-processability of the host-dopant systems is especially attractive for the construction of large-area electronics for relatively low-cost practical applications via spin-coating, roll-to-roll processing or ink-jet printing.54
Anal. calcd for C80H72Cl2Ir2N4: C, 62.20; H, 4.70; N, 3.63. Found: C, 61.59; H, 4.56; N, 3.60%.
1H NMR (700 MHz, CD2Cl2) δ 9.67 (d, 3JHH = 5.5 Hz, 4H, C6H), 7.74 (s, 4H, C3H), 7.51 (d, 3JHH = 8.0 Hz, 4H, C8H), 7.04 (s, 4H, C15H), 7.01 (s, 4H, C17H), 6.83 (m, 8H, C5H and C9H), 6.68 (dd, 3JHH ∼ 7.5 Hz, 4H, C10H), 5.92 (d, 3JHH = 8.0 Hz, 4H, C11H), 2.39 (s, 12H, C16Me), 2.13 (s, 12H, C18Me), 2.12 (s, 12H, C14Me).
13C{1H} NMR (176 MHz, CD2Cl2) δ 168.49 (C2), 151.58 (C6), 150.80 (C4), 144.50 (C12), 144.11 (C7), 137.90 (C16), 135.33 (C13), 135.49 (C14), 134.62 (C18), 130.03 (C11), 129.32 (C10), 128.52 (C15), 128.23 (C17), 123.71 (C8), 123.44 (C5), 121.42 (C9), 120.41 (C3), 20.79 (C16Me), 20.46 (C18Me), 20.21 (C14Me). Complex 4 was very recently reported elsewhere and analysed by 1H NMR spectroscopy.40,41
1H NMR (700 MHz, CDCl3) δ major isomer 8.94 (d, 3JHH = 5.7 Hz, 2H, C6H), 8.82 (d, 3JHH = 5.6, 2H, C6′H), 7.64 (s, 2H, C3H), 7.61 (s, 2H, C3′H), 7.49 (d, 3JHH ∼ 7.6, 2H, C8H), 7.45 (d, 3JHH = 7.6, 2H, C8′H), 7.03 (dd, 3JHH = 5.7, JHH = 1.9 Hz, 2H, C5H), 7.02 (s, 2H, C15′H), 7.00 (s, 2H, C15H), 6.97 (s, 2H, C17H), 6.95 (s, 2H, C17′H), 6.85 (dd, 3JHH = 5.7, JHH = 1.9 Hz, 2H, C5′H), 6.81–6.75 (m, 4H, C9H, C9′H), 6.73–6.67 (m, 4H, C10H, C10′H), 6.35 (d, 3JHH ∼ 7.7, 2H, C11H), 6.30 (s, 2H, NH), 6.25 (d, 3JHH ∼ 7.7, 2H, C11′H), 2.39 (s, 6H, C16Me), 2.37 (s, 6H, C16′Me), 2.16 (s, 6H, C14Me), 2.14 (s, 6H, C14′Me), 2.02 (s, 6H, C18′Me), 1.99 (s, 6H, C18Me). Minor isomer 8.68 (d, 3JHH = 5.6, 2H, C6H), 8.63 (d, 3JHH = 5.7, 2H, C6′H), 7.68 (s, 2H, C3H), 7.65 (s, 2H, C3′H), 7.51 (d, 3JHH = 7.6, 2H, C8H), 7.48 (d, 3JHH ∼ 7.6, 2H, C8′H), 7.03 (s, 2H, C17H), 7.02 (s, 4H, C15H, C15′H), 6.98 (s, 2H, C17′H), 6.84 (dd, 3JHH = 5.7, JHH = 1.9, 2H, C5H), 6.81–6.75 (m, 4H, C9H, C9′H), 6.76 (dd, 3JHH ∼ 5.7, JHH = 1.9, 2H, C5′H), 6.73–6.67 (m, 2H, C10H, C10′H), 6.35 (d, 3JHH ∼ 7.7, 2H, C11H), 6.29 (s, 2H, NH), 6.25 (d, 3JHH ∼ 7.7, 2H, C11′H), 2.38 (s, 12H, C16Me, C16′Me), 2.16 (s, 6H, C14Me, C14′Me), 2.10 (s, 6H, C18Me), 2.07 (s, 6H, C18′Me).
13C{1H} NMR (176 MHz, CDCl3) δ major isomer 174.46 (CO). 169.23 (C2), 168.98 (C2′), 154.78 (C12), 150.58 (C4), 149.88 (C4′), 149.02 (C6), 147.76 (C6′), 144.78 (C12′), 144.32 (C7), 144.30 (C7′), 137.93 (C16), 137.89 (C16′), 135.82 (C13), 135.79 (C13′), 135.45 (C14), 135.33 (C14′), 135.13 (C18), 134.98 (C18′), 132.52 (C11), 132.11 (C11′), 129.54 (C10), 129.34 (C10′), 128.58 (C15), 128.56 (C15′), 128.48 (C17), 128.35 (C17′), 124.26 (C8), 123.87 (C8′), 122.41 (C5), 122.38 (C5′), 120.69 (C9), 120.36 (C9′), 119.86 (C3), 119.42 (C3′), 21.08 (C16Me), 21.05 (C16′Me), 20.85 (C18Me), 20.82 (C18′Me), 20.59 (C14Me), 20.56 (C14′Me). Minor isomer 174.35 (CO), 169.20 (C2), 168.91 (C2′), 154.71 (C12), 150.48 (C4), 149.72 (C4′), 149.23 (C6), 147.65 (C6′), 144.78 (C12′), 144.35 (C7), 144.25 (C7′), 137.83 (C16, C16′), 135.79 (C13, C13′), 135.36 (C14), 135.33 (C14′), 135.20 (C18), 135.01 (C18′), 132.66 (C11), 132.24 (C11′), 129.50 (C10), 129.39 (C10′), 128.53 (C15), 128.52 (C15′), 128.41 (C17, C17′), 124.29 (C8), 123.85 (C8′), 122.51 (C5), 122.50 (C5′), 120.72 (C9), 120.38 (C9′), 119.76 (C3), 119.45 (C3′), 21.08 (C16Me), 21.07 (C16′Me), 20.76 (C18Me), 20.61 (C18′Me), 20.53 (C14Me, C14′Me).
MS(MALDI-TOF) m/z 1824.70 ([M + H, 191Ir, 193Ir], 100%). Anal. calcd For C102H98Ir2N6O2: C, 66.75; H, 5.32; N, 4.55. Found: C, 67.15; H, 5.41; N, 4.61%.
1H NMR (700 MHz, CD2Cl2) δ major isomer 9.03 (d, 3JHH = 5.7, 2H, C6H), 8.77 (d, 3JHH ∼ 5.7, 2H, C6′H), 7.76 (s, 2H, C3H), 7.59 (d, 3JHH ∼ 7.6, 2H, C8H), 7.45 (s, 2H, C3′H), 7.35 (s, 4H, C17H, C17′H), 7.10 (s, 4H, C15H, C15′H), 7.03 (dd, 2H, C5H), 7.02 (d, 2H, C8′H), 6.98 (dd, 2H, C5′H), 6.84 (dd, 3JHH ∼ 7.5, 2H, C9H), 6.74 (m, 2H, C10H), 6.72 (d, 3JHH = 8.6, 4H, C21/23H), 6.58 (dd, 2H, C9′H), 6.55 (m, 2H, C10′H), 6.49 (d, 3JHH = 7.8, 2H, C11H), 6.25 (d, 3JHH = 8.6, 4H, C20/24H), 6.15 (d, 3JHH = 7.8, 2H, C11′H), 2.38 (s, 12H, C16Me, C16′Me), 2.26 (s, 6H, C18′Me), 2.21 (s, 6H, C14Me), 2.19 (s, 6H, C18Me), 2.18 (s, 6H, C14′Me), 1.10 (s, CMe3). Minor isomer 9.25 (d, 3JHH = 5.6, 2H, C6H), 8.83 (d, 3JHH ∼ 5.6, 2H, C6′H), 7.76 (s, 2H, C3H), 7.60 (d, 3JHH ∼ 7.6, 2H, C8H), 7.40 (s, 2H, C3′H), 7.35 (s, 4H, C17H, C17′H), 7.10 (s, 4H, C15H, C15′H), 7.10 (dd, 3JHH = 7.2, JHH = 2.0, 2H, C5H), 7.04 (d, 2H, C8′H), 7.04 (dd, 2H, C5′H), 6.84 (dd, 2H, C9H), 6.74 (m, 2H, C10H), 6.68 (d, 3JHH = 8.6, 4H, C21/23H), 6.58 (dd, 2H, C9′H), 6.55 (m, 2H, C10′H), 6.41 (d, 3JHH = 7.7, 2H, C11H), 6.22 (d, 3JHH = 8.6, 4H, C20/24H), 6.27 (d, 3JHH = 7.8, 2H, C11′H), 2.41 (s, 6H, C16Me), 2.39 (s, 6H, C16′Me), 2.24 (s, 6H, C14Me), 2.15 (s, 6H, C14′Me), 2.02 (s, 6H, C18′Me), 1.97 (s, 6H, C18Me), 1.09 (s, CMe3).
13C{1H} NMR (176 MHz, CD2Cl2) δ major isomer 171.66 (CO), 169.43 (C2), 168.39 (C2′), 152.88 (C12), 150.77 (C4), 150.52 (C4′), 149.35 (C6), 148.45 (C12′), 147.50 (C6′), 145.87 (C22), 145.05 (C7), 143.47 (C7′), 141.79 (C19), 137.90 (C16), 137.88 (C16′), 135.92 (C13), 135.73 (C13′), 135.28 (C14), 135.27 (C14′), 134.86 (C18, C18′), 133.24 (C11), 131.75 (C11′), 129.13 (C10), 128.86 (C10′), 128.40 (C15, C15′, C17), 128.36 (C17′), 124.31 (C8), 124.02 (C21/23), 123.53 (C20/24), 123.52 (C8′), 122.88 (C5), 122.20 (C5′), 120.91 (C9), 120.47 (C3), 119.73 (C9′), 119.31 (C3′), 33.73 (C22CMe3), 30.99 (C22CMe3), 20.78 (C16Me, C16′Me), 20.58 (C18Me), 20.57 (C18′Me), 20.39 (C14Me), 20.31 (C14′Me). Minor isomer 171.62 (CO), 169.45 (C2), 168.21 (C2′), 152.96 (C12), 150.77 (C4), 150.27 (C4′), 149.23 (C6), 148.64 (C12′), 147.63 (C6′), 145.67 (C22), 145.00 (C7), 143.43 (C7′), 142.10 (C19), 137.92 (C16), 137.82 (C16′), 135.78 (C13), 135.73 (C13′), 135.28 (C14, C14′), 135.01 (C18, C18′), 133.09 (C11), 132.05 (C11′), 129.23 (C10), 128.88 (C10′), 128.40 (C15, C15′), 128.26 (C17), 128.19 (C17′), 124.26 (C8), 123.98 (C21/23), 123.64 (C20/24),123.40 (C8′), 122.83 (C5), 122.30 (C5′), 120.78 (C9), 120.19 (C3), 119.71 (C9′), 119.19 (C3′), 33.71 (C22Me3), 30.97 (C22CMe3), 20.81 (C16Me), 20.78 (C16′Me), 20.55 (C18Me), 20.49 (C18′Me), 20.37 (C14Me), 20.27 (C14′Me).
Complexes 5 and 6 readily dissolved in chlorobenzene without any aggregated particulates. Complex 4 has low solubility which is reflected in its photophysical properties. Therefore, its device characteristics were not measured. A mixture of PVK (20 mg):OXD-7 (40 wt%) and the complex (5 wt%) was spin-coated at 3000 rpm for 1 min on the top of the PEDOT:PSS layer and baked for 10 min at 110 °C. Each sample was shadow masked to produce four identical devices of area 4 × 4 mm; the samples were then introduced into a nitrogen glove box, where 2,2′,2′′-(1,3,5-benzenetriyl)tris-[1-phenyl-1H-benzimidazole] (TPBi) was evaporated as an electron injection/hole blocking layer at a rate of ∼1 Å s−1 under vacuum at a pressure of ca. 1 × 10−6 Torr, followed by 0.7 nm LiF and 100 nm Al cathodes at a rate of 0.2 and 1 Å s−1, respectively, under the same vacuum conditions. The devices were then encapsulated with DELO UV curable epoxy (Katiobond) and a 12 × 12 mm glass cover slide. The final device structure was ITO/PEDOT:PSS (40 nm)/[PVK:OXD-7 (40 wt%):Ir complex (5 wt%)] TPBi (30 nm)/LiF (0.7 nm)/Al (100 nm). For devices with an additional electron blocking layer of poly[(9,9-dioctylfluorenyl-2,7-diyl)-co-(4,4′-(N-(4-sec-butylphenyl)diphenylamine))] (TFB), this layer was spin-coated from toluene solution on the top of the PEDOT:PSS layer. The complex 6 (5 wt%) and OXD-7 (40 wt%) in PVK (Mw 90000) were spin coated from DMF. For all devices the current–voltage (I–V) characteristics and the emission intensities were measured in a calibrated Labsphere LMS-100 integrating sphere and the data acquisition was controlled using a home-written NI LabView program that controlled an Agilent Technologies 6632B power supply. The EL spectra were measured using an Ocean Optics USB 4000 CCD spectrometer supplied with a 400 μm UV-Vis fibre optic cable.
Footnote |
† Electronic supplementary information (ESI) available. CCDC 1521969 and 1521970. For ESI and crystallographic data in CIF or other electronic format see DOI: 10.1039/c7tc00628d |
This journal is © The Royal Society of Chemistry 2017 |